We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A single-center randomized, controlled trial investigating the efficacy of a mHealth ECG technology intervention to improve the detection of atrial fibrillation: the iHEART study protocol.
- Authors
Hickey, Kathleen T.; Hauser, Nicole R.; Valente, Laura E.; Riga, Teresa C.; Frulla, Ashton P.; Creber, Ruth Masterson; Whang, William; Garan, Hasan; Haomiao Jia; Sciacca, Robert R.; Wang, Daniel Y.; Masterson Creber, Ruth; Jia, Haomiao
- Abstract
<bold>Background: </bold>Atrial fibrillation is a major public health problem and is the most common cardiac arrhythmia, affecting an estimated 2.7 million Americans. The true prevalence of atrial fibrillation is likely underestimated because episodes are often sporadic; therefore, it is challenging to detect and record an occurrence in a "real world" setting. To date, mobile health tools that promote earlier detection and treatment of atrial fibrillation and improvement in self-management behaviors and knowledge have not been evaluated. This study will be the first to address the epidemic problem of atrial fibrillation with a novel approach utilizing advancements in mobile health electrocardiogram technology to empower patients to actively engage in their healthcare and to evaluate impact on quality of life and quality-adjusted life years. Furthermore, sending a daily electrocardiogram transmission, coupled with receiving educational and motivational text messages aimed at promoting self-management and a healthy lifestyle may improve the management of chronic cardiovascular conditions (e.g., hypertension, diabetes, heart failure, etc.). Therefore, we are currently conducting a randomized controlled trial to assess the efficacy of a mobile health intervention, iPhone® Helping Evaluate Atrial fibrillation Rhythm through Technology (iHEART) versus usual cardiac care.<bold>Methods: </bold>The iHEART study is a single center, prospective, randomized controlled trial. A total of 300 participants with a recent history of atrial fibrillation will be enrolled. Participants will be randomized 1:1 to receive the iHEART intervention, receiving an iPhone® equipped with an AliveCor® Mobile ECG and accompanying Kardia application and behavioral altering motivational text messages or usual cardiac care for 6 months.<bold>Discussion: </bold>This will be the first study to investigate the utility of a mobile health intervention in a "real world" setting. We will evaluate the ability of the iHEART intervention to improve the detection and treatment of recurrent atrial fibrillation and assess the intervention's impact on improving clinical outcomes, quality of life, quality-adjusted life-years and disease-specific knowledge.<bold>Trial Registration: </bold>NCT02731326 ; Verified April 2016.
- Subjects
NEW York (State); ATRIAL fibrillation; ATRIAL arrhythmias; ELECTROCARDIOGRAPHY; ELECTRODIAGNOSIS; QUALITY-adjusted life years; ATRIAL fibrillation diagnosis; ATRIAL fibrillation treatment; ACTION potentials; BEHAVIOR; COMPARATIVE studies; EXPERIMENTAL design; HEALTH attitudes; HEALTH behavior; HEART beat; HEART conduction system; LONGITUDINAL method; RESEARCH methodology; MEDICAL cooperation; RESEARCH protocols; MOTIVATION (Psychology); PATIENT education; RESEARCH; RESEARCH funding; STATISTICAL sampling; HEALTH self-care; SIGNAL processing; TELEMEDICINE; TEXT messages; EVALUATION research; RANDOMIZED controlled trials; PREDICTIVE tests; MOBILE apps; EQUIPMENT &; supplies
- Publication
BMC Cardiovascular Disorders, 2016, Vol 16, p1
- ISSN
1471-2261
- Publication type
journal article
- DOI
10.1186/s12872-016-0327-y